NVRO Company Profile and Key Details

Q: Who are the executives of NVRO?

Meredith VornholtVice President of Global MarketingMr. D. Keith GrossmanChairman, Chief Executive Officer & PresMr. Roderick H. MacLeodSenior Vice President & Chief Financial OfficerMs. Niamh Louise PellegriniSenior Vice President & Chief Commercial OfficerMs. Julie D. DeweyChief Communications & Investor Relations OfficerMr. Patrick SchmitzVice President of OperationsMr. Richard B. CarterChief Accounting OfficerMr. Kashif RashidSenior Vice President, Gen. Counsel, Corporation Sec. & Chief Compliance OfficerMs. Lori M. CianoSenior Vice President & Chief HR OfficerDr. David Caraway M.D., Ph.D.Senior Vice President & Chief Medical OfficerMr. Michael Collier CarterVice President of Global SalesMr. Jon R. ShearSenior Vice President of Corporation Devel.Mr. Donald A. MiddlebrookSenior Vice President of Clinical & Regulatory AffairsMr. Christofer ChristoforouSenior Vice President of Technical OperationsMr. Kevin R. ThornalGroup Pres of Global Diagnostic Solutions

NYSE : NVRO

Nevro

$5.84

At Close 4:00 PM

Not Actively Trading

64.08

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Nevro Corp. (NVRO) stock remained unchanged at $5.84 a share on NYSE. The stock opened at $5.84, fluctuating between $5.84 to $5.86 during the session.

Stock Snapshot

5.84

Prev. Close

224.09M

Market Cap

5.84

Day Low

-1.908496732026144

P/E Ratio

-3.06

EPS (TTM)

-2.02

Cash Flow per Share

5.84

Open

38.37M

Number of Shares

5.86

Day High

89.19%

Free Float in %

8.08

Book Value

751.5K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Apr 02, 2025	5.84	5.86	5.84	5.84	750.12K
Apr 01, 2025	5.84	5.85	5.84	5.84	236.88K
Mar 31, 2025	5.83	5.85	5.83	5.84	640.77K
Mar 28, 2025	5.84	5.85	5.84	5.84	238.3K
Mar 27, 2025	5.85	5.85	5.84	5.84	223.05K
Mar 26, 2025	5.84	5.85	5.83	5.85	765.45K
Mar 25, 2025	5.83	5.84	5.82	5.84	3.14M
Mar 24, 2025	5.79	5.80	5.78	5.79	631.8K
Mar 21, 2025	5.77	5.80	5.77	5.77	1.58M
Mar 20, 2025	5.78	5.80	5.78	5.78	2.38M
Mar 19, 2025	5.79	5.81	5.78	5.78	1.77M
Mar 18, 2025	5.78	5.80	5.75	5.79	1.21M
Mar 17, 2025	5.79	5.81	5.77	5.78	3.48M
Mar 14, 2025	5.80	5.81	5.79	5.80	1.6M
Mar 13, 2025	5.79	5.82	5.78	5.79	1.12M
Mar 12, 2025	5.79	5.80	5.77	5.78	1.46M
Mar 11, 2025	5.80	5.80	5.78	5.78	1.11M
Mar 10, 2025	5.73	5.79	5.73	5.78	1.12M
Mar 07, 2025	5.78	5.79	5.77	5.77	497.33K
Mar 06, 2025	5.77	5.80	5.77	5.79	637.6K

Contact Details

Redwood City, CA 94065

United States

https://www.nevro.com 650 251 0005

About Company

Nevro Corp. is a medical technology firm that delivers solutions for individuals experiencing persistent pain, serving markets both domestically in the United States and across the globe. The company's core business involves the development and market introduction of the Senza spinal cord stimulation (SCS) system, an advanced, clinically supported neuromodulation platform specifically engineered to alleviate chronic pain. This portfolio encompasses its newer generations, the Senza II and Senza Omnia systems. Additionally, Nevro offers its proprietary 10 kHz Therapy, providing neuromodulation approaches grounded in robust clinical evidence for effective chronic pain management. Its products are distributed through a diverse strategy, utilizing a dedicated direct sales team complemented by a network of specialized sales agents and independent distributors. Founded in 2006, Nevro Corp. maintains its corporate headquarters in Redwood City, California.

Stock Peers

SYK

-22.34-6.42%

Stryker Corporation$325.70 BIO

-1.24-0.38%

Bio-Rad Laboratories, Inc.$325.48 PEN

1.36+0.43%

Penumbra, Inc.$321.19 BIO-B

11.13+3.60%

Bio-Rad Laboratories, Inc.$320.50 RMD

2.42+1.16%

ResMed Inc.$210.98 GKOS

-1.8-1.07%

Glaukos Corporation$166.72 ITGR

20.35+20.18%

Integer Holdings Corporation$121.21 ABT

0.09+0.09%

Abbott Laboratories$105.70 ZBH

-1.03-1.08%

Zimmer Biomet Holdings, Inc.$93.93 EW

-0.85-0.98%

Edwards Lifesciences Corporation$86.07

Frequently Asked Questions

What is the current Nevro Corp. (NVRO) stock price?

Nevro Corp. (NYSE: NVRO) stock price is $5.84 in the last trading session. During the trading session, NVRO stock reached the peak price of $5.86 while $5.84 was the lowest point it dropped to. The percentage change in NVRO stock occurred in the recent session was 0% while the dollar amount for the price change in NVRO stock was $0.00.

NVRO's industry and sector of operation?

The NYSE listed NVRO is part of Medical - Devices industry that operates in the broader Healthcare sector. Nevro Corp. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of NVRO?

Meredith Vornholt
Vice President of Global Marketing
Mr. D. Keith Grossman
Chairman, Chief Executive Officer & Pres
Mr. Roderick H. MacLeod
Senior Vice President & Chief Financial Officer
Ms. Niamh Louise Pellegrini
Senior Vice President & Chief Commercial Officer
Ms. Julie D. Dewey
Chief Communications & Investor Relations Officer
Mr. Patrick Schmitz
Vice President of Operations
Mr. Richard B. Carter
Chief Accounting Officer
Mr. Kashif Rashid
Senior Vice President, Gen. Counsel, Corporation Sec. & Chief Compliance Officer
Ms. Lori M. Ciano
Senior Vice President & Chief HR Officer
Dr. David Caraway M.D., Ph.D.
Senior Vice President & Chief Medical Officer
Mr. Michael Collier Carter
Vice President of Global Sales
Mr. Jon R. Shear
Senior Vice President of Corporation Devel.
Mr. Donald A. Middlebrook
Senior Vice President of Clinical & Regulatory Affairs
Mr. Christofer Christoforou
Senior Vice President of Technical Operations
Mr. Kevin R. Thornal
Group Pres of Global Diagnostic Solutions

How NVRO did perform over past 52-week?

NVRO's closing price is 84.52% higher than its 52-week low of $3.17 where as its distance from 52-week high of $13.30 is -56.09%.

How many employees does NVRO have?

Number of NVRO employees currently stands at 1,099.

Link for NVRO official website?

Official Website of NVRO is: https://www.nevro.com

How do I contact NVRO?

NVRO could be contacted at phone 650 251 0005 and can also be accessed through its website. NVRO operates from 1800 Bridge Parkway, Redwood City, CA 94065, United States.

How many shares of NVRO are traded daily?

NVRO stock volume for the day was 751.5K shares. The average number of NVRO shares traded daily for last 3 months was 1.3M.

What is the market cap of NVRO currently?

The market value of NVRO currently stands at $224.09M with its latest stock price at $5.84 and 38.37M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	1099
Beta	0.82
Sales or Revenue	$425.17M
5Y Sales Change%	-0.083%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Medical - Devices

Employees	1099
Beta	0.82
Sales or Revenue	$425.17M
5Y Sales Change%	-0.083%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Medical - Devices

NVRO Company Profile and Key Details

Nevro

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Earnings & Analyst Outlook

Financial & Profitability Overview

Quarterly Financial Highlights

Dividend & Fair Value

Shareholding & Insider Activity

Company Overview

Valuation Metrics

Price Forecast & Outlook

Key Takeaways